Table 2.
Clinical practice guideline | Agree-II domain | Rating | |||||||
---|---|---|---|---|---|---|---|---|---|
Scope and purpose | Stakeholder involvement | Rigor of development | Clarity of presentation | Applicability | Editorial independence | Combined overall rating | Three key domains scorea | Non-key domains scoreb | |
Grupo de Trabajo, 201838 | 100 | 83 | 71 | 89 | 58 | 100 | 83 | 85 | 82 |
National Institute for Health and Care Excellence, 201937 | 83 | 72 | 72 | 83 | 83 | 92 | 92 | 79 | 83 |
MacQueen et al, 201641 | 89 | 78 | 70 | 67 | 60 | 83 | 75 | 77 | 72 |
Beyond Blue, 201142 | 69 | 81 | 63 | 92 | 52 | 83 | 83 | 76 | 71 |
Cheung et al, 201843 | 97 | 75 | 82 | 92 | 42 | 71 | 83 | 76 | 77 |
Driot et al, 202044 | 67 | 83 | 44 | 44 | 29 | 75 | 50 | 67 | 47 |
Seo et al, 201845 | 75 | 64 | 50 | 78 | 56 | 71 | 67 | 62 | 70 |
Ministerio de Salud, 2013a46 | 89 | 61 | 58 | 72 | 29 | 42 | 67 | 54 | 63 |
Garland et al, 201647 | 78 | 53 | 63 | 56 | 48 | 42 | 58 | 53 | 61 |
Ministerio de Salud, 2013b48 | 83 | 61 | 67 | 67 | 29 | 25 | 67 | 51 | 60 |
AGREE-II, Appraisal of Guidelines for Research and Evaluation, Second Edition.
Three key domains (stakeholder involvement, rigor of development, editorial independence).
Non-key domains (scope and purpose, clarity of presentation, applicability); high-quality score ≥70; minimum quality score 50 to <70; low-quality score <50.